Research Articles | Page 14 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? May 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Clonal Hematopoiesis and therapy related MDS/AML Mar 2019 Best Practice & Research. Clinical Heamatology myelodysplastic syndromes (MDS)
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis. Mar 2013 Biochem Cell Biol myelodysplastic syndromes (MDS)
Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria Apr 2012 BioDrugs paroxysmal nocturnal hemoglobinuria (PNH)
Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms Mar 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation Oct 2016 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Share with addtoany.com.